Skip to content
- Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-TR2 study.
- Takamatsu S, Yoshihara K, Baba T, Shimada M, Yoshida H, Kajiyama H, Oda K, Mandai M, Okamoto A, Enomoto T, Matsumura N.
- Br J Cancer. 2023 Jan 2. doi: 10.1038/s41416-022-02122-9. Epub ahead of print.
- Widespread genomic/molecular alterations of DNA helicases and their clinical/therapeutic implications across human cancer.
- Qin X, Wang J, Wang X, Huang T, Fang Z, Yan L, Fan Y, Xu D.
- Biomed Pharmacother. 2022 Dec 29;158:114193. doi: 10.1016/j.biopha.2022.114193. Epub ahead of print.
- Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer.
- Zhang L, Guan S, Meng F, Teng L, Zhong D.
- Front Oncol. 2022 Dec 14;12:1035808. doi: 10.3389/fonc.2022.1035808.
- The use of Ctrough for the therapeutic drug monitoring of olaparib in patients with ovarian cancer.
- Stanisławiak-Rudowicz J, Szałek E, Grzebalska M, Urjasz H, Michalak M, Mądry R, Grześkowiak E.
- Eur Rev Med Pharmacol Sci. 2022 Dec;26(24):9426-9436. doi: 10.26355/eurrev_202212_30694.